Search Within

Dmitriy Zamarin

  1. "Melanoma and Immunotherapeutics Service"
Formats
  1. Journal Article (26)
  2. Meeting Abstract (17)
  3. Guidelines (2)
  4. Book Section (1)
Groups
  1. Department of Medicine (46)
  2. GDMT, Medicine (46)
  3. Gynecologic Medicine Service (46)
  4. Gynecology Disease Management Team (46)
  5. Melanoma and Immunotherapeutics Service (46)
  6. Solid Tumor Oncology Division (46)

More Groups

People
  1. Jedd Wolchok (34)
  2. Taha Merghoub (33)
  3. Jacob Ricca (12)
  4. Rikke Holmgaard (12)
  5. Mathieu Gigoux (8)
  6. Cailian Liu (7)

More People

Years
  1. 2023 (2)
  2. 2022 (4)
  3. 2021 (3)
  4. 2020 (7)
  5. 2019 (3)
  6. 2018 (5)

More Years

Publications
  1. Journal for ImmunoTherapy of Cancer (10)
  2. Gynecologic Oncology (4)
  3. Cancer Immunology Research (3)
  4. Cell (3)
  5. JCO Precision Oncology (2)
  6. JNCI: Journal of the National Cancer Institute (2)

More Publications

Publishers
  1. Biomed Central Ltd (10)
  2. Elsevier Inc. (6)
  3. American Association for Cancer Research (5)
  4. Cell Press (5)
  5. Nature Publishing Group (4)
  6. American Society of Clinical Oncology (3)

More Publishers

Results (46)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • BRCA mutations, homologous DNA repair deficiency, tumor mutational burden, and response to immune checkpoint inhibition in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Selenica, P.; Zhou, Q.; Iasonos, A.; Callahan, M.; Feit, N. Z.; Boland, J.; Vazquez-Garcia, I.; Mandelker, D.; Zehir, A.; more...
    JCO Precision Oncology (2020)

    Fulltext@MSK | Save
  • Utility of serum CA-125 monitoring in patients with ovarian cancer undergoing immune checkpoint inhibitor therapy
    Journal Article

    Boland, J. L.; Zhou, Q.; Iasonos, A. E.; O'Cearbhaill, R. E.; Konner, J.; Callahan, M.; Friedman, C.; Aghajanian, C.; Sabbatini, P.; Zamarin, D.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine
    Journal Article

    Campesato, L. F.; Budhu, S.; Tchaicha, J.; Weng, C. H.; Gigoux, M.; Cohen, I. J.; Redmond, D.; Mangarin, L.; Pourpe, S.; Liu, C.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • Safety, immunogenicity, and clinical efficacy of durvalumab in combination with folate receptor alpha vaccine TPIV200 in patients with advanced ovarian cancer: A phase II trial
    Journal Article

    Zamarin, D.; Walderich, S.; Holland, A.; Zhou, Q.; Iasonos, A. E.; Torrisi, J. M.; Merghoub, T.; Chesebrough, L. F.; Mcdonnell, A. S.; Gallagher, J. M.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Blockade of AHR activation by IDO/TDO-derived kynurenine restricts cancer immune suppression
    Meeting Abstract

    Campesato, L. F.; Budhu, S.; Gigoux, M.; Tchaicha, J.; Pourpe, S.; Liu, C.; Zamarin, D.; Manfredi, M. G.; McGovern, K.; Wolchok, J. D.; more...
    Cancer Immunology Research (2020)

    Fulltext@MSK | Save
  • Consensus guidelines for the definition, detection and interpretation of immunogenic cell death
    Guidelines

    Galluzzi, L.; Vitale, I.; Warren, S.; Adjemian, S.; Agostinis, P.; Martinez, A. B.; Chan, T. A.; Coukos, G.; Demaria, S.; Deutsch, E.; more...
    Journal for ImmunoTherapy of Cancer (2020)

    Fulltext@MSK | Save
  • Computed tomography-derived radiomic metrics can identify responders to immunotherapy in ovarian cancer
    Journal Article

    Himoto, Y.; Veeraraghavan, H.; Zheng, J.; Zamarin, D.; Snyder, A.; Capanu, M.; Nougaret, S.; Vargas, H. A.; Shitano, F.; Callahan, M.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • Blockade of IDO/TDO downstream effectors restricts a Treg-macrophage suppressive axis and resistance to anti-PD-1 therapy
    Meeting Abstract

    Campesato, L.; Budhu, S.; Tchaicha, J.; Gigoux, M.; Cohen, I.; Mangarin, L.; Redmond, D.; Pourpe, S.; Liu, C.; Zappasodi, R.; more...
    Journal for ImmunoTherapy of Cancer (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • Immune-active microenvironment in small cell carcinoma of the ovary, hypercalcemic type: Rationale for immune checkpoint blockade
    Journal Article

    Jelinic, P.; Ricca, J.; Van Oudenhove, E.; Olvera, N.; Merghoub, T.; Levine, D. A.; Zamarin, D.
    JNCI: Journal of the National Cancer Institute (2018)

    Fulltext@MSK | Save